Rozanolixizumab

ATC L04AL02 · 9 markets · 21 records

Rozanolixizumab 9 markets · 21 records Forms

US 4 records · 1 strengths

CA 4 records · 1 strengths

GB 3 records · 3 strengths

AU 3 records · 3 strengths

  • 280 mg/2 mLinjectionRYSTIGGO also in GB
  • 140 mg/mLinjectionRYSTIGGO rozanolixizumab 140 mg/mL solution for injection for infusion vial unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

HK 3 records · 1 strengths

    3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
    With a brand name Con nombre comercial 有商品名 有商品名RYSTIGGO SOLUTION FOR INJECTION 280MG/2ML ×9

    Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

    ES 1 records · 1 strengths

    TW 1 records · 1 strengths

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

      FR 1 records · 1 strengths

      • 140 mg/1 mLinjectionRYSTIGGO 140 mg/mL, solution injectable also in ES

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.